LTGO logo

LATIGO BIOTHERAPEUTICS INC

LTGONASDAQ
๐Ÿ† #2466 by market capUS Equity
$13.03โ–ผ $0.28 (โˆ’2.10%)
Market closed ยท at close
๐Ÿ””
Track LTGO
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ผ 2.1%
7dโ–ฒ 0.2%
14dโ–ฒ 4.1%
30dโ–ผ 12.4%
ytdโ€”
1yโ€”
๐ŸฆMarket Cap
$784M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
0.0%
Slowing
๐Ÿ“ŠGross Margin
0.0%
Thin
๐Ÿ’ตFCF Margin
0.0%
Thin
โš–๏ธP/S Ratio
0.0x
Cheap
Otter Score
โ€”
Insufficient data

Trading Snapshot

Day Range
$12.72 โ€“ $13.28
52-Week Range
$10.24 โ€“ $25.93
Volume (shares)
14,082
Avg Volume (shares)
โ€”
Shares Outstanding
60.2M
Next Earnings
โ€”

Fundamentals Snapshot

Annual Revenue
โ€”
Last Q Revenue
โ€”
P/E Ratio
-5.5
P/S Ratio
0.0x
EPS (TTM)
$-2.84
Dividend Yield
0.00%
LTGO logo

LATIGO BIOTHERAPEUTICS INC

LTGO
Financial Trends

Financial history unavailable.

StockOtter ยท stockotter.space

About LATIGO BIOTHERAPEUTICS INC

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.